Author： Kroep Judith R Gelderblom Hans
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.18, Iss.1, 2009-01, pp. : 69-75
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Targeted therapy combos promising for breast cancer
Inpharma, Vol. 1, Iss. 1640, 2008-01 ,pp. :
Access to resources
Recommend
NEDD4: A Promising Target for Cancer Therapy
Current Cancer Drug Targets, Vol. 14, Iss. 6, 2014-07 ,pp. :
Gefitinib promising as second-line therapy for oesophageal cancer
Inpharma, Vol. 1, Iss. 1469, 2005-01 ,pp. :
gp130: a promising drug target for cancer therapy
Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. :